- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 118.28M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $146.71M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $165.69M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $855.01M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $510.16M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $5.36B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $5.38B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.3B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.29B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $10.88B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $10.9B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 117.96M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $63.93M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $167.87M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.42 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.42 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $17.29M |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.69M |